Transform Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Transform Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,698	Closed	-$737K	–	242
2023 Q3	$737K	Sell	12,698 -40,607	-76%	-$2.49M	0.08%	140
2023 Q2	$3.41M	Sell	53,305 -82,515	-61%	-$5.53M	0.31%	96
2023 Q1	$9.41M	Buy	135,820 +4,174	+3%	+$294K	0.89%	36
2022 Q4	$9.47M	Sell	131,646 -2,291	-2%	-$173K	1.06%	31
2022 Q3	$9.52M	Buy	133,937 +2,490	+2%	+$181K	1.24%	19
2022 Q2	$10.2M	Sell	131,447 -4,822	-4%	-$367K	1.52%	14
2022 Q1	$9.95M	Sell	136,269 -1,332	-1%	-$89.4K	1.12%	25
2021 Q4	$8.58M	Sell	137,601 -5,826	-4%	-$342K	0.9%	38
2021 Q3	$8.49M	Buy	143,427 +29,775	+26%	+$1.96M	0.97%	32
2021 Q2	$7.59M	Buy	113,652 +54,523	+92%	+$3.56M	0.93%	40
2021 Q1	$3.73M	Buy	59,129 +7,007	+13%	+$436K	0.75%	49
2020 Q4	$3.23M	Sell	52,122 -45,330	-47%	-$2.79M	0.68%	51
2020 Q3	$5.88M	Sell	97,452 -2,223	-2%	-$134K	0.95%	39
2020 Q2	$5.86M	Buy	99,675 +9,321	+10%	+$558K	1%	33
2020 Q1	$5.04M	Buy	90,354 +75,735	+518%	+$4.63M	1.07%	27
2019 Q4	$938K	Buy	14,619 +382	+3%	+$21.9K	0.15%	123
2019 Q3	$722K	Sell	14,237 -11,357	-44%	-$534K	0.13%	130
2019 Q2	$1.16M	Buy	+25,594	New	+$1.19M	0.17%	124
2018 Q2	–	Sell	-4,087	Closed	-$259K	–	217
2018 Q1	$259K	Hold	4,087	–	–	0.05%	211
2017 Q4	$250K	Hold	4,087	–	–	0.05%	227
2017 Q3	$261K	Hold	4,087	–	–	0.09%	190
2017 Q2	$228K	Sell	4,087 -54	-1%	-$2.94K	0.26%	59
2017 Q1	$225K	Buy	4,141 +54	+1%	+$2.96K	0.08%	194
2016 Q4	$239K	Hold	4,087	–	–	0.09%	189
2016 Q3	$220K	Hold	4,087	–	–	0.09%	187
2016 Q2	$301K	Buy	+4,087	New	+$289K	0.13%	172

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Transform Wealth's BMY Position: Q4 2023 in Review

Transform Wealth sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 12,698 shares — an estimated $737K sold.

Transform Wealth first reported a position in BMY in Q2 2016 and held it in 26 quarters. The position peaked at $10.2M in Q2 2022. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Transform Wealth reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Transform Wealth sold 12,698 Bristol-Myers Squibb shares in Q4 2023, an estimated $737K.
Transform Wealth first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 26 quarters.
Transform Wealth's Bristol-Myers Squibb position peaked at $10.2M in Q2 2022.
2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Transform Wealth's 13F filing for Q4 2023, filed 18 Jan 2024.